Rating History for Innate Pharma S.A. (ipha) by Leerink
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 8/11/2026 | Daina Graybosch | Upgrade | Outperform (Market Perform) |
4.00 (N/A) |
2.22 (2.15) |
-3.15% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 8/11/2026 | Daina Graybosch | Upgrade | Outperform (Market Perform) |
4.00 (N/A) |
2.22 (2.15) |
-3.15% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||